Skip to main content

BLIP

NDC 82966-222 · Blip Products, Inc.

Generic namenicotine polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength2 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

82966-222-00 — 1 CONTAINER in 1 CARTON (82966-222-00) / 27 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

82442-734 — Nicotine Polacrilex, 82442-741 — nicotine polacrilex, 82442-802 — nicotine polacrilex, 82442-873 — Nicotine Polacrilex, 82442-899 — nicotine polacrilex, 82442-957 — Nicotine Polacrilex, 82442-971 — nicotine polacrilex, 82966-001 — NICOTINE POLACRILEX MINI, 82966-002 — NICOTINE POLACRILEX MINI, 82966-012 — Nicotine polacrilex, 82966-269 — Nicotine Polacrilex, 82966-303 — Nicotine Polacrilex, 82966-309 — Nicotine Polacrilex, 82966-734 — Nicotine Polacrilex, 82966-957 — Nicotine Polacrilex, 82966-971 — nicotine polacrilex, 83253-262 — nicotine polacrilex, 83253-264 — Nicotine Polacrilex, 83253-978 — nicotine polacrilex, 83253-979 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels